Test Early, for a Strong Defense.

We are committed to innovation that empowers individuals to take greater
control of their health with a cost-effective, easy-to-use, time-saving solution.

Contact

Vision

Our vision is to revolutionize healthcare by developing a user-friendly, at-home blood screening kit that provides a rapid health status indication.

QuickStick was designed to be an
all-in-one, simple-to-use blood
collection device.

Kit Contents

Quick Stick

Typical Blood Screening Package

Market Size

The total at-home testing market is expected to reach $45.6 Billion in 2031, growing at a CAGR of 10.5% (2022-2031)*
There are currently 3.5M men with Prostate Cancer in the US. It’s recommended that patients screen 2-3 times annually. This equates to ~9M-12M blood screenings that are currently being taken in the providers office, or an independent lab, costing physicians and patients time and money. The National Cancer Institute estimated that there were 288,000 new cases of prostate cancer and 34,700 deaths in 2023.
Prostate Cancer Diagnostics Market**
(2023-2034, USD Billion)
*www.alliedmarketresearch.com **precedenceresearch.com

Early Detection Matters

Saves Lives
Improves Treatment Outcomes
Less Aggressive Treatment
Better Quality of Life
Increased Awareness

QuickStick User Journey

Gain Understanding

Safe, easy to use, inexpensive, all-in-one blood screening kit that can be completed in the convenience and comfort of the consumer's home.

Detect Early

Launch with prostate screening, then select which cancers or infectious diseases to include in the QuickStick offering.

Receive Rapid Results for:

  • Cancers

  • Contagious diseases

  • Alzheimer's & PTSD

  • Diabetes, MS

Build Awareness

Educate patients on the benefits of early detection.
‍
Coordinate and assist with next steps based on screening results.

About the Founder

A prostate cancer survivor, Chris Nelson is a proven entrepreneur who has successfully built and exited several business in the digital, wireless, and customer support sectors. These experiences were the impetus to create QuickStick, a patent pending health status indicator. Chris is also focused on creating a nationwide prostate cancer support group.